Dear Georges
Let's be precise in the assumptions
1) Based on the following conservative SOC Overal Survival for cancer stage III and IVa (cel sci inclusion criteria) :
Year Survival%
1 84
2 71
3 63
4 57
5 54
6 49
7 46
8 43
2) Having calibrated the events table spreadsheet with % MK improvement benefits so that the 2 dates where we know the number of events do match the model (Feb 2017 : 133 events and Feb 2018 : 208 events)
3) I can output an end point being reached by October 2019, and MK benefit being aroung 25%, which matches Cel SCI satements that study will complete by 2019 (rather second half than first half)
THIS SAID :
==========
* Due your own DD and make your investment decision accordingly : I can be proven wrong by any SOC survival proven really much better than anything existing so far in litterature for cancer stage III and IVa
* For those who don't believe in mass predictions made on invididuals behaviour which differ from individual to individual, I will answer by this quote from L. Boltzmann : "Nothing is more practical than a good theory". (Boltzmann is the physisics who discovered the kinetic theory of gases and who was able to predict macroscopic behaviour of gases (PVT) based on the only fact that they are made on invidual molecules behaving randomly)